Drug Design, Development and Therapy

“Digital Drugs” for Musculoskeletal Pain: From Evaluation Tools to Rehabilitation and Therapy Solutions

Musculoskeletal (MSK) pain represents a major global health challenge, contributing to significant disability and reduced quality of life. Conventional therapeutic approaches often fail to fully address the complex biopsychosocial dimensions of chronic pain, leading to the need for innovative, integrative strategies. In recent years, the concept of "Digital Drugs" has emerged, referring to digital health solutions that modulate pain perception through technology-driven interventions.